Sonoma Pharmaceuticals (SNOA) Other Working Capital Changes (2010 - 2026)

Sonoma Pharmaceuticals' Other Working Capital Changes history runs 17 years deep, the most recent figure standing at -$38000.0 for Q1 2026.

• On a quarterly basis, Other Working Capital Changes fell 2858.82% year-over-year to -$1.0 million in Q1 2026; TTM through Mar 2026 was -$452000.0, a 159.77% decrease from a year earlier, with the FY2026 full-year figure at -$452000.0, down 159.77% from the prior year.
• Other Working Capital Changes retreated to -$1.0 million in Q1 2026 per SNOA's latest filing, from $528000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $448000.0 in Q2 2025 and bottomed at -$79000.0 in Q1 2023.
• The 5-year median for Other Working Capital Changes is -$34000.0 (2025), against an average of $30176.5.
• Across the five-year window, Other Working Capital Changes tumbled 154.84% in 2023 and jumped 914.55% in 2025, its largest moves.
• Year by year, Other Working Capital Changes stood at -$1.2 million in 2022, then soared by 94.24% to -$68000.0 in 2023, then surged by 44.12% to -$38000.0 in 2024, then surged by 1489.47% to $528000.0 in 2025, then sank by 290.53% to -$1.0 million in 2026.
• Per Business Quant, the three latest SNOA Other Working Capital Changes figures stand at -$1.0 million (Q1 2026), $528000.0 (Q4 2025), and -$422000.0 (Q3 2025).